Thursday, August 01, 2013
On November 22, 2013 the School of Medicine will launch a major initiative, Accelerating Innovation and Discovery in Medicine, aimed at significantly and measurably increasing the pace and scope of clinical and basic sciences research that ultimately impacts human health. A cornerstone of this initiative will be the formation of an external Scientific Advisory Council, which will visit us annually and provide critical advice on our research portfolio, programs and plans, as well as offer guidance and support for junior faculty presenters.
This effort will be kicked off with a full-day symposium, the “Festival of Science,” to celebrate the groundbreaking research being conducted on campus. To celebrate this auspicious event, Francis Collins, MD, PhD, Director of the National Institutes of Health, will give the inaugural keynote address.
The first Scientific Advisory Council consists of five internationally acclaimed biomedical researchers and physician-scientists:
Rita Colwell, PhD
Carol Greider, PhD
Philip Needleman, PhD
Ralph Snyderman, MD
Elias Zerhouni, MD
“I am thrilled that, arguably, the world’s most preeminent scientists have agreed to be a part of this important initiative,” said Dean E. Albert E. Reece, MD, PhD, MBA, Vice President for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine. “When I invited these distinguished scientists to join us for this important project, not only were they eager to help, several of them mentioned how impressed they were with the dynamic progress the School of Medicine has made over the past several years,” added the Dean.
Three academic units will be featured each year at the Festival of Science to showcase the breadth and depth of the work ongoing at the School of Medicine. The symposium will give presenters an opportunity to receive feedback and advice from the Scientific Advisory Council and their colleagues during the open sessions. Presenters and School of Medicine leaders also will have the chance to speak with Council members during small-group meetings. This year, projects from the Department of Pharmacology, the Department of Surgery, and the Institute for Genome Sciences will be highlighted, which will reflect a sampling of our robust basic, translational and clinical research portfolio. - Julie Wu